Human African trypanosomiasis : treatment and drug resistance network for sleeping sickness : report of the sixth steering committee meeting 28-29 May 2002
World Health Organization. (2002). Human African trypanosomiasis : treatment and drug resistance network for sleeping sickness : report of the sixth steering committee meeting 28-29 May 2002. World Health Organization. https://apps.who.int/iris/handle/10665/67682
Gov't Doc #WHO/CDS/CSR/EPH/2002.20
MétadonnéesAfficher la fiche complète
Affichage des documents associés par titre et sujet
Control of human african trypanosomiasis: a strategy for the African Region: report of the Regional Director Regional Committee for Africa, 55 (2011-06-23)1. Human African trypanosomiasis (HAT) is caused by trypanosomes that are transmitted by the tsetse fly. HAT is the only vector-borne parasitic disease with a geographical distribution limited to the African continent. ...
Report on a meeting of the Product Development Team for African Trypanosomiasis Chemotherapy to review the comparative study of the 14-day versus the 7-day treatment of late stage t.b. gamiense African trypanosomiasis with eflornithine : WHO, Geneva, 14 July 1998 UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases; Product Development Team for African Trypanosomiasis Chemotherapy (World Health OrganizationWorld Health Organization, 1998)